Middle Meningeal Artery Embolization for the Treatment of Subdural Hematomas With TRUFILL® n-BCA (MEMBRANE)
Diseases of the Cardiovascular System
What is the purpose of this trial?
This is a prospective, multi-center, open-label, randomized controlled study in which subjects can receive standard of care (SOC) alone or SOC and TRUFILL n-BCA MMA embolization for the treatment of chronic subdural hematomas (cSDH).
- Ages18 years - 90 years
- Trial withCerenovus
- Start Date11/09/2021
- End Date05/31/2024
- Last Updated11/11/2022
- Study HIC#2000030366